SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-002431
Filing Date
2021-06-09
Accepted
2021-06-09 11:08:53
Documents
4
Period of Report
2021-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT canna_8k.htm 8-K 20660
2 AMENDMENT OF AGREEMENT OF PURCHASE AND SALE canna_ex1005.htm EX-10.5 168766
3 PRESS RELEASE canna_ex9906.htm EX-99.6 7680
4 GRAPHIC image_002.jpg GRAPHIC 101096
  Complete submission text file 0001683168-21-002431.txt   337921
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 211004408
SIC: 2834 Pharmaceutical Preparations